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Abstract 
AIM
To evaluate a step up approach: Taking macrobiopsies and 
performing excision biopsies in patients with suspected 
rectal cancer in which biopsies taken though the flexible 
endoscope showed benign histology. 
METHODS
Patients with a rectal neoplasm who underwent flexible 
endoscopy and biopsies were included. In case of 
benign biopsies rigid rectoscopy and macrobiopsies were 
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employed. If this failed to prove malignancy, transanal 
endoscopic microsurgery (TEM) was used in a final effort 
to establish a certain preoperative diagnosis. The pre-
operative results were compared with the findings after 
surgical excision and follow up to calculate the reliability 
of this algorithm.
RESULTS
One hundred and thirty-two patients were included. One 
hundred and ten patients with a carcinoma and 22 with 
an adenoma. Seventy-five of 110 carcinomas were proven 
malignant after flexible endoscopy. With the addition of 
rigid endoscopy and taking of macrobiopsies, this number 
increased to 89. Performing TEM excision biopsies further 
enlarged the number of proven malignancies to 100.
CONCLUSION
The step-up approach includes taking macrobiopsies through 
the rigid rectoscope and performing excision biopsies using 
transanal endoscopic microsurgery in addition to flexible 
endoscopy. This approach, reduced the number of missed 
preoperative malignant diagnoses from 32% to 9%.
Key words: Rectal cancer; Histology; Biopsy; Macrobiopsy; 
Transanal endoscopic microsurgery; Sampling error
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Increasing the number of biopsies taken through 
a flexible endoscope, taking macrobiopsies and performing 
excision biopsies with transanal endoscopic microsurgery 
can reduce the number of missed preoperative malignant 
diagnoses in patients with rectal cancer. 
Bökkerink GMJ, van der Wilt GJ, de Jong D, van Krieken 
HHJM, Bleichrodt RP, de Wilt JHW, Bremers AJA. Value of 
macrobiopsies and transanal endoscopic microsurgery in the 
histological work-up of rectal neoplasms: A retrospective study. 
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INTRODUCTION
Adequate pre-treatment histological sampling is of 
paramount importance for the optimal treatment of rectal 
neoplasms. A wide spectrum of surgical and neoadjuvant 
treatments is available. In case of benign disease, surgical 
excision alone, will suffice. For a majority of the malignant 
tumors however, a combination of neoadjuvant therapy 
and total mesorectal excision is indicated to optimize 
local control[1-5]. High complete response rates after 
chemoradiation therapy have led to the development of 
organpreserving strategies[6-8]. 
Although the oncological benefits of neoadjuvant 
treatments are evident, the acute toxicity and long term 
side effects of chemoradiation therapy are considerable. 
Therefore, administration of neoadjuvant chemoradiation 
therapy requires definite proof of malignancy. As the 
diagnosis of malignancy based on imaging alone may 
be erroneous because of the risk of overstaging MRI 
based imaging, these neoadjuvant treatments require 
histological evidence of malignancy before treatment can 
commence. 
A preoperative histological diagnosis is usually 
obtained by taking biopsies through a flexible endoscope. 
Flexible endoscopy offers a high tumor detection rate[9] 
and the possibility to take biopsies. However, from limited 
evidence available, sensitivity for malignancy on these 
biopsies is suboptimal at best[10-12]. The most important 
reason for this is that biopsies taken through flexible 
endoscopes are small and sometimes too superficial 
to demonstrate high grade neoplasia[13]. In case of 
superficial biopsies, the diagnosis of malignancy relies 
solely on tissue structure and atypical appearance of cells 
(Figure 1). One way to overcome this problem is to take 
more biopsies. Indeed, several authors demonstrated 
a correlation between sensitivity and the number of 
biopsies taken from a suspected lesion. When 3 or 4 
biopsies were taken, the sensitivity for invasive growth 
varied between 50% and 86%[10-12]. By taking up to 10 
biopsies, the sensitivity increased to 78% to 100% (Table 
1).
Another way to increase the sensitivity of pre-
treatment histological sampling for the detection of 
malignancy is to increase the volume and depth of the 
biopsy. Although considered old-fashioned by many 
clinicians, rigid rectoscopy is an easy, cost effective, 
fast and well-tolerated tool for examination of the 
rectum[14], that enables the endoscopist to take so-called 
“macrobiopsies”. Macrobiopsies are 2-10 times larger in 
three dimensions and approximately 50 times larger in 
volume than those obtained with flexible rectoscopy. The 
A B
Figure 1  Biopsy focepses and histological slides. A: Biopsy forceps used 
with the flexible endoscope: Representative slide of a malignant tumor, HE × 
20; B: Biopsy forceps used with the rigid endoscope, representative slide of the 
same tumor, HE × 20.
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Table 1  Flexible endoscopy: Sensitivity for invasive growth; correlation with the number of biopsies
rigidity of the biopsy forceps also enables the endoscopist 
to push the forceps against the tumor so that deeper 
layers of the rectal wall can be included in the biopsy, and 
to “palpate” the lesion and take the biopsies from the 
firmer parts of the lesion selectively. For these reasons, 
rigid rectoscopy may perform better with respect to 
sampling error than flexible endoscopy. 
Sometimes, even macrobiopsies may fail to demon-
strate invasive growth. In an ultimate effort to obtain 
sufficient histological confirmation of malignancy without 
interfering with the optimal treatment strategy, transanal 
endoscopic microsurgery (TEM) may be used in these 
cases to perform an excision biopsy. TEM is an invasive 
way to obtain a histological diagnosis. However, it does 
have the advantage that it can sometimes be used as a 
definitive treatment for low risk T1 carcinomas.
Although there are sound theoretical grounds to 
expect that rigid rectoscopy and TEM can boost the 
sensitivity of the pre-treatment histological work-up for 
suspected rectal cancer, this has never been empirically 
investigated. The aim of this article, therefore, is to 
assess the accuracy, therapeutic value and tolerability of 
taking additional macrobiopsies and performing excision 
biopsies with TEM in patients with suspected rectal 
cancer: a step-up approach.
MATERIALS AND METHODS
Patients 
All patients who underwent biopsy through a flexible 
endoscope, as part of the work-up for surgery of a rectal 
neoplasm, between January 2005 and January 2011 
in the Radboud University Nijmegen Medical Center, 
Nijmegen, The Netherlands were analyzed. Patient 
selection was based on the database of surgical procedure 
in our hospital. All patients who underwent surgical 
excision of a rectal neoplasm [local excision; transanal 
endoscopic microsurgery or total or partial mesorectal 
excision: Abdominoperineal resection or (low) anterior 
resetion] where selected. The medical records of all 
patients were reviewed for demographic characteristics 
and for endoscopy, pathology and surgical reports. 
Diagnostic and therapeutic algorithm
This is a retrospective analysis of the diagnostic and 
therapeutic step-up algorithm, which was followed during 
the study period. This algorithm is shown in Figure 2. 
Macrobiopsies were taken through the rigid sigmoidoscope 
in case of benign histology after flexible endoscopy and 
persisting clinical or radiological suspicion for malignancy, 
macrobiopsies were taken through rigid rectoscopy. 
TEM was performed in case of a benign or cT1 tumor on 
endorectal ultrasound (ERUS). 
Equipment 
Flexible endoscopes were the CF140S 70 cm sigmoidoscope 
and CF 140 Ⅰ colonoscope (Olympus, Tokyo, Japan). For 
flexible endoscopy, a 2.2 mm radial jaw biopsy forceps 
was used (Boston Scientific, Natick, United States) 
(Figure 1). For colonoscopy complete bowel preparation 
was used. Sedation and analgesia given upon request. 
During colonoscopy multiple biopsies were taken from 
any suspicious lesions. A 250 mm × 18 mm disposable 
rectoscopy tube, Heine, Herrsching, Germany was used 
for rigid rectoscopy. Biopsies were taken with a Franital 
biopsy forceps with a 5 mm × 10 mm bite (Figure 1). 
Bowel preparation before rigid and flexible sigmoidoscopy 
consisted of a single soap enema. All procedures were 
performed by, or under direct supervision of, consultant 
level surgeons or gastroenterologists. 
TEM-surgery was performed by one of the authors 
(AB) as first described by Buess[15] using the stereo-optic 
Wolf rectoscope (Wolf, Knittlingen, Germany). 
Statistical analysis
The additional yield of taking macrobiopsies and per-
forming excision biopsies was analyzed by comparing 
all biopsies with the definitive excision specimen. The 
differences in sensitivity between the number of samples 
taken through the flexible endoscope was tested with the 
χ 2 test for trends. 
RESULTS
Patients
One hundred and thirty-two patients (82 males and 50 
females) underwent flexible endoscopy with biopsies as 
part of the work-up for a rectal neoplasm (tumor located 
below 15 cm from the anal verge). Median age was 63 
years (range: 27-92).
Number of biopsies ≤ 2 3 4 5 6 7 8 ≥ 9
Marshall (1993) Sens 68.3 78.3 78.3 78.3
n = 701 70 70 70 70
Colleypriest (2009) Sens  80% 86% 86% 88% 98% 100% 98% 100%
n = 217 Not specified
Dabos (2011) Sens  50% 72% 70% 76% 88% 91% 100%
n = 149 Not specified
Current study Sens  40% 30% 76% 75% 83% 50% 91% 72%
n = 113 7 12 21 17 14 16 13 13
1Authors studied the value of reviewing 2, 4 and 6 additional biopsies, taken in every patient.
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Flexible endoscopy
The histological work-up of all 132 patients is shown 
in Figure 3. At final pathology 110 patients had an ade-
nocarcinoma, of which 75 (68%) were detected with 
flexible endoscopy only. The other 22 patients had a villous 
adenoma. One of the tumors, classified as malignant 
based on biopsies taken through the flexible endoscope 
(snare polypectomy), showed benign histology after 
(transanal) resection. 
The number of biopsies was documented for 113 
patients and varies from 1 to 14, with a median of 4 
biopsies (Table 1). There was a significant correlation 
between the number of biopsies and a correct histological 
diagnosis (P = 0.020; 2-sided χ 2 test for trends). Taking 
4 or more biopsies resulted in a significant higher 
sensitivity than taking 3 or less (P = 0.004; 2-sided χ 2 
test for trends).  Prior probability of malignancy was 
83.3% in this group. Sensitivity and specificity were 68% 
and 95% respectively. A malignant result is useful with 
a posterior probability of malignancy of 99% (95%CI: 
92%-100%). Benign histology after flexible endoscopy 
is clearly inconclusive, leaving a posterior probability of 
malignancy of 62% (95%CI: 55%-69%).
Rigid rectoscopy and macrobiopsies
In 29 of the 56 patients who were diagnosed with a benign 
tumor after flexible endoscopy, additional rigid endoscopy 
was performed. With this addition, 14 previously 
undetected carcinomas were diagnosed. In this selected 
group of 29 patients who underwent rigid endoscopy, 
prior probability of malignancy was 75.9%. Sensitivity and 
specificity were 64% and 100% respectively, which makes 
a malignant histology after rigid endoscopy useful with 
a posterior probability of malignancy of 100% (95%CI: 
68%-100%). Benign histology after rigid endoscopy 
is leaves a posterior probability of malignancy of 53% 
(95%CI: 41%-68%). The remaining 27 patients did 
not undergo additional macrobiopsies taken through a 
rigid endoscope because there was no clinical suspicion 
of malignancy and endorectal ultrasound did not show 
invasion deeper than the submucosa (clinical benign or 
clinical T1). Further management was not dependent on 
histology analysis, since these lesions were regarded as 
indication for TEM for complete removal.
TEM
A total of 44 patients underwent TEM (Figure 3), 
32 patients after benign biopsies (combined flexible 
and rigid), 12 after malignant biopsies (clinical and 
radiological T1). With this addition, another 11 invasive 
carcinomas were detected. The number of detected 
carcinomas increased from 89 out of 110 (81%) to 100 
out of 110 (91%). 
Histology after TEM showed 18 adenomas, 4 in situ 
carcinomas, and 22 carcinomas. After TEM, 10 patients 
underwent a completion TME because of unfavorable 
histological findings. The excision specimen of one of 
these 10 patients was perforated at the former local 
excision site. One patient with an ypT3 tumor was unfit 
to undergo a total mesorectal excision and was treated 
with short course radiotherapy and TEM after a 6 wk 
interval. No major complications were observed nor 
preoperative perforations or conversions to laparotomy 
after TEM in this group. One patient with postoperative 
rectal blood loss needed transfusion. 
Neoadjuvant treatment 
A total of 79 patients received neoadjuvant treatment 
in 4 different schemes according to tumor stage and 
general condition. Thirty-eight patients received 5 Gy × 
5 Gy in the week prior to surgery according to protocol 
for T2 and T3 tumors. Thirty Patients with a radiologically 
involved circumferential resection margin received 
neoadjuvant chemoradiation therapy (25 Gy × 2 Gy with 
concomitant capecitabine) and delayed surgery after 8 
wk. Eleven patients whose general condition did not allow 
chemoradiation therapy (CRT) and who required tumor 
regression received 5 Gy × 5 Gy (n = 9) or long course 
radiotherapy (24 Gy × 2 Gy) (n = 2) and delayed surgery 
as decided by a multidisciplinary team. 
Rectal neoplasm
Histology flexible endoscopy
Benign Malignant
Clinically malignant
Histology rigid endoscopy
Imaging
≤ T1 > T1
TEM
Unfavorable histology
TME
Figure 2  Diagnostic and therapeutic algorithm. TEM: Transanal endoscopic 
microsurgery.
Inclusion
Histology flexible 
endoscopy
TEM
TME
Histology rigid 
endoscopy
Malignant Benign
132
56
15
7 14 1
76
14
5 647
4 2 4 29 6 692
1
2
Figure 3  Yield of macrobiopsies en excision biopsies. 1Fourteen not earlier 
detected carcinomas; 2Eleven not earlier detected carcinomas.
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Surgery
Forty-four patients underwent TEM, 53 underwent a LAR 
and a further 34 underwent APR, 1 patient with MSH6 
mutation underwent a subtotal colectomy with LAR. After 
TEM 10 patients underwent a completion TME. Definitive 
histology after resection showed 18 adenomas, 4 in situ 
carcinomas, 101 carcinomas and 9 complete responses 
after neoadjuvant treatment.
DISCUSSION 
In the present study we demonstrated that macrobiopsies 
obtained through a rigid endoscope and excision biopsies 
by TEM are valuable additional tools to obtain a correct 
preoperative histological diagnosis in a significant number 
of patients with suspected rectal cancer.
Over time, flexible endoscopy has replaced rigid 
rectoscopy because of its superior (videoscopic) visua-
lization of the entire colon, better mobility and deeper 
intubation[16-20] and subsequently a good tumor detection 
rate[9]. However, when it comes to the diagnostic sensitivity 
to detect malignancy in rectal tumors, our results are in 
accordance with the literature and confirm the disappointing 
overall performance of flexible endoscopy. The proportion 
of false negative biopsies after flexible endoscopy alone 
was 32%. This can be explained by the number of biopsies 
taken in our study. With a median number of biopsies of 4, 
a sensitivity of 70% can be expected. 
Increasing the number of biopsies with flexible 
endoscopy can increase the number of detected malig-
nancies in the group of suspicious rectal neoplasms (Table 
1). However, increasing the number of biopsies through 
flexible endoscopy, as suggested by some authors[10-12], 
was not our main strategy to increase diagnostic sen-
sitivity, because these biopsies are often too superficial to 
show high grade neoplasia[13]. Our algorithm included rigid 
endoscopy and TEM as additional steps. 
In terms of accuracy, the selected group of patients 
with false negative biopsies after flexible endoscopy, 14 
additional patients with a malignancy were identified 
with rigid endoscopy, and with TEM, another 11 patients. 
In total, 100 of 110 malignancies could be diagnosed 
preoperatively. This means that the proportion of car-
cinomas of which the malignant nature would have been 
proven in time was 32% with flexible endoscopy alone 
and was reduced to 9% in the evaluated algorithm. This 
is a significant reduction with high therapeutic value.
Regarding procedure-related morbidity, both rigid 
endoscopy and TEM were well-tolerated. In our experience, 
TEM did not cause an increase in positive circumferential 
resection margins (CRM) in TME as determined by 
standardized pathological evaluation according to Quircke[21]. 
Conclusion 
With the current treatment options for patients with rectal 
cancer, optimal preoperative histological diagnosis is 
essential. Besides the combinations with radical surgery, 
multimodality organ sparing treatments are becoming 
more and more accepted. Short-term results show high 
percentages of pathologic complete response[6,22] and 
acceptable oncological outcome[6,7], adequate histological 
sampling seems of paramount importance for these 
new treatment strategies, not only before but also after 
(chemo)radiation therapy. 
In the present study we demonstrated that macro-
biopsies obtained through a rigid endoscope and excision 
biopsies by TEM are valuable additional tools in obtaining 
a correct preoperative histological diagnosis in a significant 
number of patients with suspected rectal cancer. Pro-
spective trials are needed to compare the yield of these 
strategies to increasing the amount of biopsies through 
flexible endoscopy. Evidence-based recommendations 
for guidelines regarding the histological work-up of rectal 
neoplasms can be based on those trials.
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